Brandon McFarlin

Nephrology MSL | Medical Affairs | Bridging Clinical Practice, Innovation, and Scientific Strategy to Improve Patient Outcomes | Opinions are my own

[NKF Nephrology Professionals @NKF_NephPros]

Thank you to all our attendees, presenters, and NKF staff for making #NKFClinicals a big success! Interested in NKF resources for professionals? Learn more about all we have to offer: https://t.co/7epplWqguo

[Brandon McFarlin @Brandonmcfarli]

Sudden Cardiac Arrest Associated with Hemodialysis: A Community-Based Study - PubMed https://t.co/bsFGfA9tot

[ASN Kidney360 @ASNKidney360]

In this issue of Kidney360, Ahmad et al. report the presence of renin-angiotensin system (RAS) components in EVs isolated from blood and urine of a small cohort of hypertensive patients. In this editorial, Dr. Romer A Gonzalez-Villalobos argues that the most important contribution of Ahmad et al. is to bring light into the potential role of EV in regulating Ang peptide formation in humans. https://t.co/VstECAxwXb

[ASN Kidney360 @ASNKidney360]

Monitoring of serum alkaline phosphatase (ALP) is recommended in the management of CKD-mineral bone disorder (MBD) because of associations with poor outcome among dialysis patients. This study found that higher serum ALP was independently and linearly associated with higher all-cause and CV mortality and new hip fracture in Japanese dialysis patients. https://t.co/YFZFeKUMdo

[Brandon McFarlin @Brandonmcfarli]

@CJASN What were the leading reasons for discontinuation?

[ASN Publications @asnpublications]

Patients with CKD are encouraged to choose refined grains instead of whole grains as part of the low-phosphorus diet for managing CKD-mineral and bone disorders (CKD-MBD). This study found that intake of whole grains was not associated with CKD-MBD biomarkers. https://t.co/I0HpjiXWm0
@ogutierrez136
@JohnsHopkinsEpi
@JHUWelchCenter

[Clintoria R. Williams, PhD, FAHA, FAPS @clintoria]

Honored to be the founding Scientific Director of Wright State's Cardio-Renal Institute! Proud to lead pioneering research in cardiovascular and kidney health with the support of our new endowment. Excited for what’s ahead! #Research #CardioRenalInstitute
https://t.co/MNlBpEg3U9